多房棘球蚴亮氨酸氨基肽酶优势抗原表位的鉴定
王蕾1 , 魏威1 , 周培1 , 刘海生1 , 杨宝良2 , 李润乐3 , 汤锋1
1.青海大学高原医学研究中心,教育部高原医学重点实验室,青海省高原医学应用基础重点实验室,西宁 810001; 2.青海省红十字医院,西宁 810001; 3.青海大学基础医学部,西宁 810001
Identification of the Dominant Antigen Epitopes of Leucine Aminopeptidase in Echinococcus multilocularis
WANG Lei1 , WEI Wei1 , ZHOU Pei1 , LIU Hai-sheng1 , YANG Bao-liang2 , LI Run-le3 , TANG Feng1
1. Research Center for High Altitude Medicine, Qinghai University; Key Laboratory of Plateau Medicine, Ministry of Education; Qinghai Key Laboratory of Plateau Medical Application Foundation, Xining 810001, China; 2. Red Cross Hospital of Qinghai Province, Xining 810001, China; 3. Basic Medicine Department, Qinghai University, Xining 810001, China
摘要 目的 根据预测多房棘球蚴亮氨酸氨基肽酶(Leucine aminopeptidase, LAP)抗原表位的结果,进一步鉴定其优势的T细胞和B细胞抗原表位。方法 构建重组质粒pCzn1-LAP后进行蛋白原核表达与纯化,将纯化的LAP蛋白进行动物免疫后,利用脾脏淋巴细胞增殖、流式细胞术、ELISA pot、ELISA等方法鉴定优势抗原表位。最后,利用SWISS-MODEL软件对LAP蛋白3D结构建模,PyMOL软件对鉴定的LAP优势抗原表位分布进行准确定位。结果 pCzn1-LAP菌株诱导表达的蛋白约为57 kDa,蛋白经过复性后成功纯化。流式细胞术鉴定的Th1型优势抗原表位为LAP79-63 、LAP396-410 和LAP106-120 ;Th2型优势抗原表位为LAP13-28 、LAP495-510 和LAP396-410 。ELISA pot鉴定的Th1型优势抗原表位为LAP396-410 、LAP504-518 和LAP106-120 ;Th2型优势抗原表位为LAP504-518 、LAP313-328 和LAP396-410 。BALB/c小鼠血清的抗原表位特异性ELISA筛选出的优势B表位结果为LAP464-479 、LAP495-510 和LAP313-328 。LAP蛋白3D结构建模成功,LAP优势抗原表位分布于表面居多。结论 多房棘球蚴LAP蛋白优势T细胞和B细胞抗原表位鉴定成功,使得研制抗多房棘球蚴感染的多价表位疫苗成为可能。
关键词 :
多房棘球蚴 ,
亮氨酸氨基肽酶 ,
抗原表位
Abstract :The present study aimed to identify dominant T cell and B cell epitopes in leucine aminopeptidase of Echinococcus multilocularis . Prokaryotic expression of LAP protein was performed, and the purified LAP protein was used to immunize mice. Then an lymphocyte-proliferation assay, flow cytometry, ELISA pot, and ELISA were used to identify the dominant antigen epitopes. Finally, the 3D structure was modeled with SWISS-MODEL software, and PyMOL software was used to accurately locate LAP’s dominant epitopes. The expressed LAP protein was approximately 57 kDa, and the protein was successfully purified after renaturation. The dominant antigen epitopes of Th1 were identified by flow cytometry as LAP79-63 , LAP396-410 , and LAP106-120 . The epitopes of Th2 were LAP13-28 , LAP495-510 , and LAP396-410 . The dominant antigen epitopes identified by ELISA pot were LAP396-410 , LAP504-518 , and LAP106-120 . The epitopes of Th2 were LAP504-518 , LAP313-328 , and LAP396-410 . The predominant B cell epitopes identified by the ELISA were LAP464-479 , LAP495-510 , and LAP313-328 . Bioinformatics analysis showed that the antigenic peptides were mostly located on the surface of the protein. The dominant T cell and B cell epitopes of LAP were successfully identified and may contribute to the development of a multivalent epitope vaccine against Echinococcus multilocularis infection.
Key words :
Echinococcus multilocularis
LAP
antigen epitope
收稿日期: 2020-08-24
基金资助: 国家自然科学基金项目(No.81860299)、青海省科技厅自然科学基金青年项目(No.2020-ZJ-963Q)及青海大学医学院中青年科研基金团队项目(No.2019-KT-01)联合资助
通讯作者:
汤锋,Email: leileitang1984@163.com; ORCID: 0000-0002-3168-8157 李润乐,Email: aprilmomoa@163.com; ORCID: 0000-0002-6611-708X
引用本文:
王蕾, 魏威, 周培, 刘海生, 杨宝良, 李润乐, 汤锋. 多房棘球蚴亮氨酸氨基肽酶优势抗原表位的鉴定[J]. 中国人兽共患病学报, 2021, 37(4): 292-300.
WANG Lei, WEI Wei, ZHOU Pei, LIU Hai-sheng, YANG Bao-liang, LI Run-le, TANG Feng. Identification of the Dominant Antigen Epitopes of Leucine Aminopeptidase in Echinococcus multilocularis . Chinese Journal of Zoonoses, 2021, 37(4): 292-300.
链接本文:
http://www.rsghb.cn/CN/10.3969/j.issn.1002-2694.2021.00.041 或 http://www.rsghb.cn/CN/Y2021/V37/I4/292
[1] 温浩, 吐尔干艾力·阿吉, 邵英梅, 等. 棘球蚴病防治成就及面临的挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6):466-471. [2] Ma L, Chen DC, Zou SY, et al.Epidemiological characteristics of hepatic echinococcosis, concurrent cerebral echinococcosis, and pulmonary echinococcosis in Ganzi County, Sichuan Province, China[J]. Medicine (Baltimore), 2020, 99(15):e19753. DOI:10.1097/MD.0000000000019753 [3] Wen H, Vuitton L, Tuxun T, et al.Echinococcosis: Advances in the 21st Century[J]. Clin Microbiol Rev, 2019, 32(2):e00075-18. DOI:10.1128/CMR.00075-18 [4] Casulli A.Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis[J]. Lancet Glob Health, 2020, 8(4):e470-e471. DOI: 10.1016/S2214-109X(20)30066-8 [5] 伍卫平, 王虎, 王谦, 等. 2012-2016年中国棘球蚴病抽样调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1):1-14. [6] 赵德, 冯磊, 张强, 等. 表位疫苗的设计及应用研究进展[J]. 生命科学, 2012, 24(2):174-180. [7] Kim Y G, Lee Y, Jung J W, et al.Epitope peptide amphiphile-based nanofiber as an effective vaccine for viral infectious diseases[J]. J Nanosci Nanotechnol, 2020, 20(9):5329-5332. DOI: 10.1166/jnn.2020.17655 [8] Ren H, Zhou P.Epitope-focused vaccine design against influenza A and B viruses[J]. Curr Opin Immunol, 2016, 42:83-90. DOI: 10.1016/j.coi.2016.06.002 [9] Ma M, Liu J, Jin S, et al.Development of tumour peptide vaccines: From universalization to personalization[J]. Scand J Immunol, 2020, 91(6):e12875. DOI: 10.1111/sji.12875 [10] Combadière B, Beaujean M, Chaudesaigues C, et al.Peptide-based vaccination for antibody responses against HIV[J]. Vaccines (Basel), 2019,7(3):105. DOI: 10.3390/vaccines 7030105 [11] Vakili B, Nezafat N, Zare B, et al.A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB/c mice[J]. Med Microbiol Immunol, 2020,209(1):69-79. DOI: 10.1007/s00430-019-00640-7 [12] Drinkwater N, Malcolm TR, Mcgowan S.M17 aminopeptidases diversify function by moderating their macromolecular assemblies and active site environment[J]. Biochimie, 2019, 166:38-51. DOI: 10.1016/j.biochi.2019.01.007 [13] Matsui M, Fowler JH, Walling LL.Leucine aminopeptidases: diversity in structure and function[J]. Biol Chem, 2006, 387(12):1535-1544. DOI: 10.1515/BC.2006.191 [14] Maggioli G, Acosta D, Silveira F, et al.The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep[J]. Vaccine, 2011, 29(48):9057-9063. DOI: 10.1016/j.vaccine.2011.09.020 [15] Zhang S, Cai X, Luo X, et al.Molecular cloning and characterization of leucine aminopeptidase gene from Taenia pisiformis [J]. Exp Parasitol, 2018, 186:1-9. DOI: 10.1016/j.exppara.2018.01.012 [16] Wu M, Yan M, Xu J, et al.Expression, tissue localization and serodiagnostic potential of Echinococcus granulosus leucine aminopeptidase[J]. Int J Mol Sci, 2018, 19(4):1063. DOI: 10.3390/ijms19041063 [17] 杨宝良, 洛桑达哇, 刘文磊, 等. 多房棘球绦虫亮氨酰氨肽酶抗原表位的生物信息学预测[J]. 中国高原医学与生物学杂志, 2017, 38(4):223-234. [18] Rodríguez-Rubio L, Serna C, Ares-Arroyo M, et al.Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages[J]. J Antimicrob Chemother, 2020(11):11. DOI: 10.1093/jac/dkaa311 [19] Nguyen AN, Song JA, Nguyen MT, et al.Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21 using maltose-binding protein[J]. Sci Rep, 2017, 7(1):16139. DOI: 10.1038/s41598-017-16167-x [20] 黄欣梅, 赵冬敏, 刘宇卓, 等. 鹅坦布苏病毒E蛋白结构域Ⅲ的原核表达及抗原性分析[J]. 南方农业学报, 2015, 46(1):150-154. DOI: 10.3969/j: issn.2095-1191.2015.1.150 [21] Li R, Yang Q, Guo L, et al.Immunological features and efficacy of the recombinant subunit vaccine LTB-EMY162 against Echinococcus multilocularis metacestode[J]. Appl Microbiol Biotechnol, 2018, 102(5):2143-2154. DOI: 10.1007/s00253-018-8771-5 [22] Guo L, Yin R, Xu G, et al.Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils[J]. Helicobacter, 2017, 22(6). DOI: 10.1111/hel.12428 [23] 刘佳, 高习习, 李巍, 等. ELISpot技术检测猪抗口蹄疫γ干扰素方法的建立[J]. 中国畜牧兽医, 2017, 44(1):53-58. DOI: 10.16431/j.cnki.1671-7236.2017.01.007 [24] Pang MQ, Tang F, Wang HJ, et al.Prediction and Identification of Epitopes in the Emy162 Antigen of Echinococcus multilocularis [J]. Acta Parasitol, 2020:1-10. DOI: 10.2478/s11686-020-00231-0 [25] 刘贝贝. Bt Cry1类毒素广谱噬菌体抗体的筛选与鉴定[D]. 南京:南京农业大学, 2016. [26] Studer G, Rempfer C, Waterhouse AM, et al.QMEANDisCo-distance constraints applied on model quality estimation[J]. Bioinformatics, 2020, 36(8):2647. DOI: 10.1093/bioinformatics/btaa058 [27] 曹璐. 高危型HPV(HPV16/18/52/58)重组病毒样颗粒疫苗抗原活性分析方法的建立及初步应用[D]. 厦门:厦门大学, 2017. [28] 宋帅, 李春玲, 贾爱卿, 等. 抗原表位研究方法进展[J]. 动物医学进展, 2010, 31(12):87-91. [29] 孙娟, 王愉涵, 刘艳, 等. 抗原表位鉴定方法的研究进展[J]. 国外医学(医学地理分册), 2017, 38(3):291-295. DOI: 10.3969/j.issn.1671-7236.2012.07.015 [30] 文雪霞, 陈化兰, 熊永忠, 等. 抗原表位鉴定方法的研究进展[J]. 中国畜牧兽医, 2012, 39(7):66-70. DOI: 10.3969/j.issn.1671-7236.2012.07.015 [31] Kula T, Dezfulian MH, Wang CI, et al.T-Scan: a genome-wide method for the systematic discovery of T cell epitopes[J]. Cell, 2019, 178(4):1016-1028. DOI: 10.1016/j.cell.2019.07.009 [32] Mosmann TR, Cherwinski H, Bond MW, et al.Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins[J]. J Immunol, 1986, 136(7):2348-2357. DOI: 10.1007/s00031-008-9037-6 [33] 李志, 杨婷婷, 徐维家, 等. CD4 +T淋巴细胞与自身免疫性疾病的关系研究进展[J]. 国际检验医学杂志, 2012, 33(23):2891-2894. [34] Romagnani S.T cell subpopulations[J]. Chem Immunol Allergy, 2014, 100:155-164. DOI: 10.1159/000358622 [35] Adan A, Alizada G, Kiraz Y, et al.Flow cytometry: basic principles and applications[J]. Crit Rev Biotechnol, 2017, 37(2):163-176. DOI: 10.3109/07388551.2015.1128876 [36] Liu L, Chen D, Wang J, et al.Advances of single-cell protein analysis[J]. Cells, 2020, 9(5):1271. DOI: 10.3390/cells9051271 [37] Ahmad TA, Eweida AE, El-Sayed LH.T-cell epitope mapping for the design of powerful vaccines[J]. Vaccine Reports, 2016, 6:13-22. DOI: 10.1016/j.vacrep.2016.07.002 [38] Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA.Fundamentals and methods for T- and B-cell epitope prediction[J]. J Immunol Res, 2017, 2017:2680160. DOI: 10.1155/2017/2680160 [39] 陈丽来. HPV58型E6和E7抗原的HLA限制性CTL表位的预测、筛选及免疫反应性的鉴定[D]. 南宁:广西医科大学, 2016. [40] 艾力亚力·艾力, 孙立, 李波霖, 等. 中国包虫病患者经济负担研究的系统评价[J]. 中国循证医学杂志, 2019, 19(12):1416-1422.
[1]
寇永杰, 李瑞, 郑亚东, 夏天奇, 时恒枝, 王璞, 杨兴, 孙晓林. 多房棘球绦虫RNA结合蛋白28的鉴定 [J]. 中国人兽共患病学报, 2022, 38(6): 490-495.
[2]
曹得萍, 张耀刚, 姜博璠, 李建华, 庞明泉, 陈根. 细粒棘球蚴和多房棘球蚴感染对Balb/c小鼠淋巴细胞亚群的影响 [J]. 中国人兽共患病学报, 2021, 37(5): 421-425.
[3]
高海军, 庞华胜, 张妍, 霍乐乐, 姜斌, 莫筱瑾, 雒艳萍, 张颋, 景涛, 徐斌, 马兴铭, 胡薇. 白黎芦醇体外对多房棘球蚴原头节和微囊的作用研究 [J]. 中国人兽共患病学报, 2021, 37(12): 1057-1063.
[4]
邢稚坤, 王二强, 廖原, 高风亦, 赵雪源, 谭小武, 俞晓凡, 吴向未. 小鼠肝细粒棘球蚴和多房棘球蚴病不同时期病灶周围组织纤维化对比 [J]. 中国人兽共患病学报, 2021, 37(11): 1008-1016.
[5]
刘川川, 马兰, 格日力, 樊海宁. 噻虫啉治疗继发性泡型包虫病的实验研究 [J]. 中国人兽共患病学报, 2020, 36(12): 1006-1013.
[6]
刘许诺,王芬,吴宏烨,李锴,范俊杰,叶彬. 两种棘球绦虫的水通道蛋白基因克隆及功能特性的比较 [J]. 中国人兽共患病学报, 2018, 34(6): 501-508.
[7]
孙慧, 李瑾, 肖婷, 徐超, 尹昆, 黄炳成, 雷战, 魏庆宽. 弓形虫微线蛋白16抗原表位区的预测及酵母表面展示 [J]. 中国人兽共患病学报, 2017, 33(9): 774-778.
[8]
郭永忠, 初伊明, 阿尔新·卡德尔, 郭宝平, 周璨林, 李军, 张文宝, 郭刚. 新疆伊犁地区尼勒克县人群泡球蚴感染病例调查及nad 2、cob 基因片段分析 [J]. 中国人兽共患病学报, 2017, 33(12): 1066-1070.
[9]
张颖颖, 王荣山, 陈旭, 金洪星, 严杰. 不可分型流感嗜血杆菌OMP6优势T-B联合抗原表位及其免疫原性研究 [J]. 中国人兽共患病学报, 2017, 33(12): 1053-1059.
[10]
何顺伟, 李洪清, 李晓燕, 赵瑞雪, 魏晓星. 多房棘球蚴LDH基因的克隆表达及免疫原性研究 [J]. 中国人兽共患病学报, 2017, 33(11): 967-971.
[11]
王慧, 李军, 郭宝平, 温浩, 张文宝. 微囊法棘球蚴继发感染小鼠动物模型的建立 [J]. 中国人兽共患病学报, 2016, 32(9): 784-788.
[12]
黄红, 张淑坤. 多房棘球蚴病的浸润和转移机制研究进展 [J]. 中国人兽共患病学报, 2016, 32(7): 670-673.
[13]
楼宏强, 高素华, 李旭升, 陈浩浩, 胡野. 基于OMP18的B细胞抗原表位的空肠弯曲菌ELISA检测方法的建立 [J]. 中国人兽共患病学报, 2016, 32(10): 889-892.
[14]
崔瑞娜, 白雪娟, 阳幼荣, 梁艳, 张俊仙, 赵卫国, 吴雪琼. 结核分枝杆菌Rv3134c蛋白抗原表位的预测 [J]. 中国人兽共患病学报, 2015, 31(6): 541-546.
[15]
吕晴, 单思, 王丽君, 巴彩凤. 猪附红细胞体ORF5 蛋白的空间结构与B细胞抗原表位预测 [J]. 中国人兽共患病学报, 2015, 31(3): 251-254.